KRAS stimulates glucose uptake by increasing glucose transporter levels on the cancer cell membrane, which promotes glucose uptake and further increases glycolysis in PDAC [13]; p53, the gene product of TP53, was demonstrated to increase glycolysis mediated by TP53-induced glycolysis and apoptosis regulator (TIGAR) [14]. Here, TP53 is linked to cancer.